RESUMO
Non-Hodgkin's lymphomas constitute one half of malignancies arising in the orbit and the ocular adnexae. Mucosa-associated lymphoid tissue (MALT)-type lymphoma is the most common histological category in this anatomic region. The incidence of ocular adnexal lymphoma of mucosa-associated lymphoid tissue-type (OAML) is increasing and recent studies offered new relevant insights in molecular, pathogenetic and therapeutic issues on these neoplasms. A pathogenetic model of antigen-driven lymphoproliferation similar to that reported for Helicobacter pylori-related gastric MALT lymphomas has been hypothesized for OAML. This notion is supported by the association between OAML and Chlamydophila psittaci infection, an association that is of likely pathogenetic relevance and may influence both the biological behavior and the therapeutic management of these neoplasms. However, this association displays evident geographical variability indicating that other etiopathogenic agents could be involved. These recent acquisitions coupled with the occurrence of chromosomal translocations and other genetic alterations, as well as additional risk factors like autoimmune disorders have contributed to render OAML an exciting challenge for a broad group of physicians and scientists. OAML is an indolent and rarely lethal malignancy that, in selected patients, can be managed with observation alone. Lymphomatous lesions are frequently responsible for symptoms affecting patient's quality of life, requiring, therefore, immediate treatment. Several therapeutic strategies are available, often associated with relevant side-effects. However, the therapeutic choice in OAML is not supported by consolidated evidence due to the lack of prospective trials. In this review, we analyze the most relevant biological, molecular, pathological and clinical features of OAML and propose some therapeutic guidelines for patients affected by this malignancy.
Assuntos
Linfoma de Zona Marginal Tipo Células B/etiologia , Neoplasias Orbitárias/etiologia , Idoso , Antibacterianos/uso terapêutico , Infecções por Chlamydophila/complicações , Infecções por Chlamydophila/tratamento farmacológico , Infecções por Chlamydophila/imunologia , Chlamydophila psittaci/imunologia , Aberrações Cromossômicas , Doença Crônica , Terapia Combinada , Neoplasias da Túnica Conjuntiva/diagnóstico , Neoplasias da Túnica Conjuntiva/etiologia , Neoplasias da Túnica Conjuntiva/imunologia , Neoplasias da Túnica Conjuntiva/microbiologia , Neoplasias da Túnica Conjuntiva/terapia , Conjuntivite/complicações , Conjuntivite/tratamento farmacológico , Conjuntivite/imunologia , Gerenciamento Clínico , Doxiciclina/uso terapêutico , Previsões , Rearranjo Gênico do Linfócito B , Humanos , Imunofenotipagem , Linfoma de Zona Marginal Tipo Células B/tratamento farmacológico , Linfoma de Zona Marginal Tipo Células B/genética , Linfoma de Zona Marginal Tipo Células B/imunologia , Linfoma de Zona Marginal Tipo Células B/microbiologia , Linfoma de Zona Marginal Tipo Células B/patologia , Linfoma de Zona Marginal Tipo Células B/radioterapia , Neoplasias Orbitárias/diagnóstico , Neoplasias Orbitárias/genética , Neoplasias Orbitárias/imunologia , Neoplasias Orbitárias/microbiologia , Neoplasias Orbitárias/patologia , Neoplasias Orbitárias/terapia , Guias de Prática Clínica como AssuntoAssuntos
Regulação da Expressão Gênica , Rearranjo Gênico do Linfócito B/genética , Genes de Imunoglobulinas/genética , Fator de Transcrição YY1/genética , Animais , Diferenciação Celular/fisiologia , Cromatina/genética , Rearranjo Gênico do Linfócito B/fisiologia , Genes de Imunoglobulinas/fisiologia , Fator de Transcrição PAX5/genética , Fator de Transcrição YY1/metabolismoRESUMO
The role of the transcription factor Yin Yang 1 (YY1) in development is largely unknown. Here we show that specific ablation of YY1 in mouse B cells caused a defect in somatic rearrangement in the immunoglobulin heavy-chain (IgH) locus and a block in the progenitor-B-to-precursor-B-cell transition, which was partially rescued by a prerearranged IgH transgene. Three-dimensional DNA fluorescence in situ hybridization analysis revealed an important function for YY1 in IgH locus contraction, a process indispensable for distal V(H) to D(H)J(H) recombination. We provide evidence that YY1 binds the intronic Ei mu enhancer within the IgH locus, consistent with a direct role for YY1 in V(H)D(H)J(H) recombination. These findings identified YY1 as a critical regulator of early B-cell development.
Assuntos
Linfócitos B/fisiologia , Regulação da Expressão Gênica , Rearranjo Gênico do Linfócito B/genética , Cadeias Pesadas de Imunoglobulinas/genética , Fator de Transcrição YY1/genética , Animais , Diferenciação Celular/fisiologia , Cromatina/genética , Imunoprecipitação da Cromatina , Citometria de Fluxo , Rearranjo Gênico do Linfócito B/fisiologia , Cadeias Pesadas de Imunoglobulinas/fisiologia , Hibridização in Situ Fluorescente , Camundongos , Fator de Transcrição PAX5/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fator de Transcrição YY1/metabolismoRESUMO
We describe a patient with a disseminated nodular cutaneous B-cell lymphoma, whose diagnosis was finally made after a long series of biopsies in different institutions in Europe and the United States. The differential diagnosis between lymphoma and pseudolymphoma was the recurrent problem throughout the patient's history because histologic and immunophenotypic criteria alone were not sufficient for differentiation. Molecular biology inconsistently detected clonal immunoglobulin rearrangements, which proves that careful clinicopathologic correlation remains mandatory. In contrast to a claimed "high-grade" malignant histology, this lymphoma responded with remission to PUVA therapy combined with intralesional corticosteroids, which is uncommon in the management of cutaneous B-lymphomas.
Assuntos
Linfoma de Células B/patologia , Pseudolinfoma/patologia , Neoplasias Cutâneas/patologia , Biópsia , DNA de Neoplasias/análise , Diagnóstico Diferencial , Rearranjo Gênico do Linfócito B , Humanos , Imuno-Histoquímica , Imunofenotipagem , Linfoma de Células B/tratamento farmacológico , Linfoma de Células B/genética , Pessoa de Meia-Idade , Terapia PUVA , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/genéticaRESUMO
Polymerase chain reaction (PCR) cloning has greatly facilitated the cloning of heavy and light chain genes from B cells and hybridomas and has been critical for the generation of natural antibody gene libraries for expression in bacteria and on filamentous phages. There remain difficulties, however, in cloning VH and VL genes from a number of mouse and rat hybridoma lines and from B cells from several other species due to insufficient sequence information. Here we describe a rapid and 'universal' strategy for cloning rearranged antibody genes from any species for which the sequence of the C segment(s) are known. First strand synthesis is primed with a biotinylated C region primer and full length cDNA is captured on streptavidin-coated magnetic beads for tailing with dGTP and terminal deoxynucleotidyl transferase. After tailing, the cDNA is captured again, amplified using polyC primers and used for direct sequencing or cloning. The use of C region primers and cDNA capture ensures that this one-side PCR procedure is efficient and rapid as well as being entirely independent of the sequence of the V segment. We demonstrate its application to the direct sequencing or cloning of the H and L chain genes from six mouse and rat hybridomas and propose that the method described will find applications in three areas: (i) cloning rearranged antibody genes in all cases in which cloning with V-J primers is not possible; (ii) repertoire studies in which an unbiased cloning procedure is required for accurate estimate of gene usage; and (iii) generation of VH and VL gene libraries from immunised animals.
Assuntos
Clonagem Molecular/métodos , Rearranjo Gênico do Linfócito B/genética , Região Variável de Imunoglobulina/genética , Reação em Cadeia da Polimerase/métodos , Sequência de Aminoácidos , Sequência de Bases , Primers do DNA/genética , DNA Complementar/síntese química , DNA Complementar/isolamento & purificação , Humanos , Hibridomas/imunologia , Dados de Sequência MolecularRESUMO
CD5+ B cells constitute a small fraction of cells in the spleen of adult mice that exhibit numerous features serving to distinguish them from the bulk of IgD++CD5- "conventional" B cells. In this review we focus on two major questions relating to this population: 1) the relationship of CD5+ B cells to other B cells; and 2) the distinctive enrichment of particular autoreactive specificities in this subset. The nature of their origins is clarified by a thorough analysis of intermediate stages of early B-cell development in both fetal and adult tissues. The reactivity to bromelain-treated mouse red blood cells serves as a prototype system for the investigation of biased specificities in CD5+ B cells. These lines of investigation lead us to propose that CD5+ B cells in the adult are the remnant of a distinct fetal B-cell differentiation pathway wherein selection of cells from this fetal/neonatal population into the adult long-lived pool results in the over-expression of certain germline-encoded autoreactivities.
Assuntos
Antígenos CD/imunologia , Linfócitos B/fisiologia , Epitopos/imunologia , Sequência de Aminoácidos , Animais , Sequência de Bases , Antígenos CD5 , Diferenciação Celular , Rearranjo Gênico do Linfócito B/genética , Rearranjo Gênico do Linfócito B/imunologia , Genes de Imunoglobulinas/imunologia , Imunoglobulina D/imunologia , Dados de Sequência MolecularRESUMO
Most, if not all, autoantibodies specific for bromelain-treated mouse erythrocytes recognize the common membrane phospholipid, phosphatidyl choline (PtC). Anti-PtC antibodies are produced by 5%-15% of CD5+ Ly-1 B cells of normal unimmunized mice, but not by detectable numbers of conventional CD5- B cells. At 1 week of age PtC-specific B cells are undetectable but then increase dramatically over the next 3 to 4 weeks to reach adult numbers. We report here that PtC-specific Ly-1 B cells in B10.H-2aH-4bp/Wts mice predominantly express either of two heavy and kappa chain variable (V) region gene combinations. In addition, the sequence and length of DH genes are conserved among cells expressing the same V gene combination, and the V kappa-J kappa junctions of one group involve unusual splice sites. Preferential V gene rearrangement models are insufficient to explain the DH and V kappa-J kappa junctional sequences or the delayed appearance of this specificity, and so they cannot solely account for the high frequency of PtC-specific cells. These characteristics are more consistent with antigen selection. We therefore attribute the frequent use of the two V region gene combinations to selection for cells that express them and conclude that the expressed V gene repertoire of Ly-1 B cells in adult mice is influenced by antigen selection. Apparently, there is no selection for mutant anti-PtC antibodies of higher affinity during the formation of the Ly-1 B repertoire because the V region genes expressed by PtC-specific cells are unmutated. Our findings are consistent with an important, germ line-encoded function for the immunoglobulin products of these gene combinations.